Intersect ENT Receives $1,018,585 Series C Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=740e2a85-cdfd-41b8-a086-1fc0e1a9bfbe&Preview=1 -
Date
9/2/2011 -
Company Name
Intersect ENT -
Mailing Address
1049 Elwell Court Palo Alto, CA 94303 -
Company Description
Intersect ENT Inc. (formerly Sinexus) is a medical device company pioneering novel therapies for Ear, Nose & Throat surgeons to utilize in providing improved treatment for their patients. -
Website
http://www.intersectent.com -
Transaction Type
Venture Equity -
Transaction Amount
$1,018,585 -
Transaction Round
Series C -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing-amended. -
M&A Terms
-
Venture Investor
Undisclosed
